Diseases, Conditions, Syndromes

Dominant Alpha variant evolved to evade our innate immune system

The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences ...

Vaccination

Cambridge needle-free coronavirus vaccine enters clinical trial

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive ...

Medications

A new medication uses protein against SARS-CoV-2

Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide collaboration. But medications against COVID-19 have as yet seen only partial success. With the support of the Bavarian Research ...

page 29 from 40